Osteopontin: A new emerging role in psoriasis

Archives of Dermatological Research

Volumn 301, Issue 6, 2009, Pages 397-404

  Buommino, Elisabetta ^a   Tufano, Maria Antonietta ^a   Balato, Nicola ^b   Canozo, Nunzia ^a   Donnarumma, Maria ^b   Gallo, Lucia ^b   Balato, Anna ^b   Ayala, Fabio ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Inflammation; Osteopontin; Psoriasis

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SKIN BIOPSY; TH1 CELL; TH2 CELL;

ANTIGENS, CD44; BIOPSY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; OSTEOPONTIN; PSORIASIS; SKIN; TH1 CELLS; TH2 CELLS;

EID: 68149163190     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0939-5     Document Type: Article

References (24)

1. L Ackermann IT Harvima 1998 Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis Arch Dermatol Res 290 353 359 10.1007/s004030050317
2. LC Borish JW Steinke 2003 Cytokines and chemokines J Allergy Clin Immunol 111 suppl 2 S460 S475 10.1067/mai.2003.108
3. JD Bos MA de Rie MBM Teeunissen 2005 Psoriasis: dysregulation of innate immunity Br J Dermatol 152 1098 1107 10.1111/j.1365-2133.2005.06645.x
4. AM Byrne DJ Bouchier-Hayes JH Harmey 2005 Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) J Cell Mol Med 9 777 794 10.1111/j.1582-4934.2005.tb00379.x (Pubitemid 43116546)
5. YJ Chen JL Shen CY Wu 2009 Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis J Am Acad Dermatol 60 225 230 10.1016/j.jaad.2008.09.046
6. A Chiocchetti M Indelicato T Bensi 2004 High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation Blood 103 1376 1382 10.1182/blood-2003-05-1748
7. B Christensen MS Nielsen KF Haselmann 2005 Posttranslationally modified residues of native human osteopontin are located in clusters. Identification of thirty-six phosphorylation and five O-glycosylation sites and their biological implications Biochem J 390 285 292 10.1042/BJ20050341
8. D Creamer M Allen R Jaggar 2002 Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor Arch Dermatol 138 791 796 10.1001/archderm.138.6.791 (Pubitemid 34625524)
9. DT Denhardt M Noda AW O'Regan 2001 Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 1055 1061 10.1172/JCI12980 (Pubitemid 32422899)
10. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31 10.1038/nm0195-27
11. J Fuchs TM Zollner R Kaufmann 2001 Redox-modulated pathways in inflammatory skin diseases Free Radic Biol Med 30 337 353 10.1016/S0891-5849(00) 00482-2
12. AA Gaspari 2006 Innate and adaptative immunity and the pathophysiology of psoriasis J Am Acad Dermatol 54 67 80 10.1016/j.jaad.2005.10.057
13. Y Kano Y Teraki T Shioara 2006 Dramatic improvement of psoriatic erythroderma after acute hepatitis: analysis of cytokine synthesis capability in peripheral blood T cells Br J Dermatol 155 455 459 10.1111/j.1365-2133.2006. 07270.x
14. CL Langrish Y Chen WN Blumenschein 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 233 240 10.1084/jem.20041257
15. D Leali P Dell'Era H Stabile 2003 Osteopontin (ETA-1) and fibroblast growth factor-2 cross-talk in angiogenesis J Immunol 171 1085 1093 (Pubitemid 36871426)
16. BS McKenzie RA Kastelein DJ Cua 2006 Understanding the IL-23-IL-17 immune pathway Trends Immunol 27 17 23 10.1016/j.it.2005.10.003
17. A Naldini D Leali A Pucci 2006 Cutting edge: IL-1 beta mediates the proangiogenic activity of osteopontin-activated human monocytes J Immunol 177 4267 4270 (Pubitemid 44469753)
18. HJ Nielsen IJ Christensen MN Svendsen 2002 Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis Inflamm Res 51 563 567 10.1007/PL00012428
19. KE Nograles LC Zaba E Guttman-Yassky 2008 Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways Br J Dermatol 159 1092 1102
20. A O'Regan JS Berman 2000 Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation Int J Exp Pathol 81 373 390 10.1046/j.1365-2613. 2000.00163.x
21. EM Paleolog S Young AC Stark 1998 Modulation of angiogenic vascular endothelial growth factor by tumour necrosis factor alpha and interleukin-1 rheumatoid arthritis Arthritis Rheum 41 1258 1265 10.1002/1529-0131(199807)41: 7<1258::AID-ART17>3.0.CO;2-1
22. G Piskin RM Sylva-Steenland JD Bos 2006 In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin J Immunol 176 1908 1915 (Pubitemid 43134336)
23. M Sticherling W Sautier JM Schröeder 1999 Interleukin-8 plays its role at local level in psoriasis vulgaris Acta Derm Venereol 79 4 8 10.1080/000155599750011606
24. A Szegedi M Aleksza A Gonda 2003 Elevated rate of Thelper1 (T(H)1) lymphocytes and serum IFN-γ levels in psoriatic patients Immunol Lett 86 277 288 10.1016/S0165-2478(03)00025-7